Micro-X

Micro-X R&D / Revenue

The R&D to Revenue Ratio of Micro-X (MX1.AX) as of Nov 5, 2026 is 0.08 %. In the previous year, R&D to Revenue Ratio was 0.08 % — a change of -1.43% (lower).

R&D / Revenue

0.08 %

YoY

-1.43%

Last updated:

R&D to Revenue Ratio of Micro-X is 2024 0.08 % . R&D to Revenue Ratio of Micro-X was 2023 0.08 % . It decreases by -1.43% lower compared to the previous year.

The Micro-X R&D / Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D / Revenue
Date
R&D / Revenue
Jan 1, 2016
1,983.63 AUD
Jan 1, 2017
18.36 AUD
Jan 1, 2018
461.29 AUD
Jan 1, 2019
21.75 AUD
Jan 1, 2020
16.94 AUD
Jan 1, 2022
0.66 AUD
Jan 1, 2023
0.08 AUD
Jan 1, 2024
0.08 AUD
The Micro-X R&D / Revenue history
YEARR&D / RevenueYoY
0.08 %-1.43%
0.08 %-87.84%
0.66 %-96.12%
16.94 %-22.13%
21.75 %-95.28%
461.29 %+2,412.34%
18.36 %-99.07%
1,983.63 %-79.96%
9,900.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Micro-X Stock analysis

What does Micro-X do? Micro-X Ltd. generates revenue through the sale of ultra-lightweight carbon nanotube-based X-ray products to healthcare, military, and veterinary sectors. The company's commercial mobile digital radiology products are used for diagnostic imaging in global healthcare, military, and veterinary applications. Key products include mobile digital X-ray machines, intermittent explosive disorder (IED) X-ray cameras, miniature baggage scanners, and computed tomography (CT) brain scanners. The firm also designs Airport Checkpoint Portal systems for the United States Department of Homeland Security, targeting security and defense applications. The primary buyers of Micro-X's products are healthcare providers, military organizations, and veterinary clinics. The company's technology enables reduced size, weight, and power requirements in X-ray equipment, making it suitable for mobile and portable use in various settings. The Airport Checkpoint Portal for the United States Department of Homeland Security represents a significant government contract segment. Micro-X's product portfolio targets both established markets like healthcare and emerging security applications. The company focuses on delivering compact, energy-efficient X-ray solutions that address mobility needs in diagnostic imaging. This approach allows Micro-X to serve diverse customer segments including medical facilities, defense contractors, and security agencies requiring advanced X-ray technology. Micro-X is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Micro-X stock

R&D to Revenue Ratio of Micro-X is 0.08 % in 2024.

R&D to Revenue Ratio of Micro-X changed from 0.08 % to 0.08 %, representing a -1.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D to Revenue Ratio Micro-X since 2006 – with annual values, charts, and detailed analysis.

The R&D to Revenue ratio shows what percentage of revenue a company invests in research and development. Higher ratios indicate stronger focus on innovation.

A 'good' varies by industry and company stage. On Eulerpool, you can compare R&D to Revenue Ratio's Micro-X with sector peers and the industry average to assess whether it is attractive.

To evaluate R&D to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for R&D to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Micro-X

All Key Metrics — Micro-X